ABSTRACT-Paeoniflorin, a major constituent of peony root, has been demonstrated to attenuate the radial maze performance deficit produced by scopolamine. In the present study, to investigate the possible involvement of ~-adrenergic systems in the paeoniflorin antagonism of the scopolamine deficit, the effects of two ~-adrenoceptor antagonists, propranolol and atenolol, on the paeoniflorin effect were examined in male Wistar rats. Paeoniflorin (1 mg/kg, p.o.) significantly attenuated the scopolamine HBr (0.3 mg/kg, i.p.) induced deficit in the choice accuracy in radial maze performance without changing the running time pro longed by scopolamine. Neither D,L-propranolol HCl, a lipophilic p-antagonist, at 3 mg/kg, i.p. nor atenolol, a hydrophilic p1-antagonist that is known to hardly ever cross the blood-brain barrier, at 1 mg/kg, i.p. impaired maze performance by itself or aggravated the scopolamine-induced deficit in radial maze per formance. Both antagonists, however, completely blocked the antagonizing effect of paeoniflorin on the scopolamine deficit. These data suggest that the 3-adrenergic systems, especially peripheral ~1-adrenergic systems, are involved in the antagonizing effect of paeoniflorin on the scopolamine deficit in radial maze per formance in rats.
In Chinese and Japanese medicine, peony root has long been used to treat various kinds of dementia as a compo nent of traditional prescriptions. This herb is known to disperse blood stagnancy and relax muscle spasms of both smooth and skeletal muscles (1) . Paeoniflorin is a water soluble substance that was isolated from peony root in 1963 (2) . The effects of this substance are reportedly in good accordance with the clinical effects of peony root (3) . Recently, Ohta et al. (4) have demonstrated that peony root extract and paeoniflorin dose-dependently at tenuate the scopolamine-induced deficit in radial maze performance in rats. Although they have suggested the in volvement of non-cholinergic systems in the paeoniflorin effect, the underlying mechanisms are still unclear.
There has been substantial evidence showing that the memory deficits produced by scopolamine are reinstated by cholinomimetic drugs such as oxotremorine, physostig mine and tacrine (5, 6) . Recent studies, however, indicate that some adrenergic drugs can attenuate the scopolamine deficits. Amphetamine, for example, reverses scopola mine-induced memory impairments in a variety of tasks (5, 7) . A norepinephrine precursor, L-threo-DOPS, and a norepinephrine uptake blocker, desipramine, have also been shown to attenuate the scopolamine-induced deficit in radial maze performance (8) . Conversely, a (3 adrenoceptor antagonist, propranolol, aggravates impair ments in water maze and passive avoidance performances following scopolamine (9) . These findings indicate that drugs that affect adrenergic functions are able to modu late the effects of scopolamine. On the other hand, it seems established that peripherally administered epinephrine improves memory retention (10) . Moreover, it attenuates the memory deficit induced by scopolamine (5, 11) and potentiates the memory-enhancing effects of physostigmine and oxotremorine (12) . Since epinephrine does not readily cross the blood-brain barrier, these facts suggest that the peripheral adrenergic system is involved in the modulation of central cholinergic functions. In the present study, to test the possible involvement of central and peripheral j3-adrenergic systems in the antagonizing effect of paeoniflorin on scopolamine-induced memory deficit, we determined the effects of two (3-adrenoceptor antagonists with different lipophilicity, i.e., the lipophilic ~-antagonist propranolol and the hydrophilic a1-an tagonist atenolol, on the paeoniflorin effect using an eight-arm radial maze task. Atenolol has a higher selectiv ity towards 131-adrenoceptors compared to propranolol and is known to hardly ever cross the blood-brain barrier (13) .
MATERIALS AND METHODS

Subjects
The subjects were male Wistar rats obtained from Japan SLC (Hamamatsu) weighing 290-390 g. The rats were 6 weeks old on arrival and were acclimatized to laboratory conditions for 1 week before being used. Four or five animals were housed in a cage with free access to water in an air-conditioned room with a 12-hr light/dark cycle (lights on, 0730-1930). The animals were main tained on a restricted feeding schedule designed to keep their body weight at approximately 85010 of the free-feed ing level. All training was conducted between 9:00 14:00.
Apparatus
An eight arm radial maze was used. Each arm (50 x 12 cm) extended from an octagonally shaped central hub (30 cm across). The platform was elevated 40 cm above the floor. Small black plastic cups (3 cm in diameter and 1 cm deep), mounted at the end of each arm, served as recepta cles for reinforcers (45 mg food pellet; Bio-Serv, French town, NJ, USA). Guillotine doors surrounded the hub.
Procedures
The procedure was detailed in our previous report (4). Prior to the maze training, each animal was handled for 5 10 min daily for 2 days and was also given 3 days to adapt to the maze. On the first day of the adaptation period, two rats at a time were placed on the maze where food pellets were scattered on the floor and in the food cups. From the second day, one rat was placed in the maze and allowed to move freely until all eight arms were chosen. Following this adaptation period, one daily train ing trial was conducted for each rat. The trial was judged complete when the rat had visited all 8 arms or had spent 10 min in the maze. Entry into an arm that the rat had not previously visited was recorded as a correct response and re-entry was counted as an error. The number of correct responses before committing the first error (No. of initial correct), the number of errors and the running time were used as the measures of radial maze performance. To cal culate the running time, the total running time was divid ed by the total number of choices. Rats that made no er rors or only one error at the eighth choice for 5 consecu tive days were used for the drug tests.
Drug treatment
The drugs used in these experiments were a muscarinic antagonist, scopolamine hydrobromide (Nacalai Tesque. Kyoto); a (3-adrenoceptor antagonist, D,L-propranolo: hydrochloride (Sigma, St. Louis, MO, USA); and peripherally acting f31-adrenoceptor antagonist, atenolo: (Sigma). These drugs were dissolved in saline and in. traperitoneally (i.p.) injected 30 min before testing. Paeoniflorin was extracted and purified as described b} Shibata et al. (2) . Paeoniflorin was dissolved in water and orally administered 90 min before testing. In each experi ment, the drugs were tested in a counterbalanced se quence to exclude any order effect.
Statistics
The effects of the drugs on the number of initial correct responses, the number of total errors and the runnin€ time were analyzed by the Kruskal-Wallis test followed b3 the Mann-Whitney U-test for multiple comparisons. Differences with a P<0.05 were considered statistical)} significant.
RESULTS
Effects of propranolol and atenolol on scopolamine dis ruption of radial maze performance Neither propranolol (3 mg/kg) nor atenolol (1 mg/kg), by itself, affected radial maze performance with respect to the initial correct responses (Fig. 1) , the number of errors and the running time (Table 1) . Scopolamine (0.3 mg/kg) significantly decreased the initial correct responses (P<0.05, Fig. 1 ) and increased the number of errors (P<0.05, Table 1 ). The running time of scopolamine treated rats was significantly longer than that of the saline group (P<0.05, Table 1 ). Neither propranolol nor atenolol changed the scopolamine-induced impairment of the initial correct responses (Fig. 1) , the number of errors and the running time ( Table 1) .
Effects of propranolol and atenolol on paeoniflorin at tenuation of scopolamine deficit Paeoniflorin (1 mg/kg) significantly attenuated the scopolamine-induced decrease in the initial correct responses (P<0.05, Figs. 2 and 3 ) and the increase in the number of errors without changing the running time prolonged by scopolamine (Tables 2 and 3) . These results agree well with our previous report (4). Propranolol (3 mg/kg) significantly antagonized the effect of paeoniflo rin on the number of initial correct responses (P<0.05, Fig. 2 ) and the number of errors (P <0.05, Table 2 ). The peripherally acting p1-antagonist atenolol also significant ly reversed the paeoniflorin-induced increase in the num ber of initial correct responses (P<0.05, Fig. 3 ) and the decrease in the number of errors (P<0.05, Table 3 ). None of these antagonists affected the running time (Tables 2 and 3) . 
DISCUSSION
Our previous study has demonstrated that paeoniflorin (0.01-1 mg/kg) attenuates the scopolamine disruption of radial maze performance in a dose-dependent manner, and that this agent is most effective at 1 mg/kg (4). The present result that 1 mg/kg paeoniflorin antagonized the scopolamine-induced impairment in choice accuracy is in good agreement with our previous report. Moreover, paeoniflorin did not change the running time prolonged by scopolamine. This finding suggests that paeoniflorin may antagonize the central, and not the peripheral effect of scopolamine, since the running time can be prolonged not only scopolamine but also by methylscopolamine, a peripherally acting scopolamine derivative, which does not affect the choice accuracy of radial maze perform ance.
In the present study, 3 mg/kg propranolol completely blocked the paeoniflorin attenuation of the scopolamine deficit. This fact indicates that (3-adrenergic systems are involved in the paeoniflorin effect. More interestingly, the hydrophilic /31-antagonist atenolol at 1 mg/kg also com pletely blocked the paeoniflorin effect. Atenolol is known to hardly ever cross the blood-brain barrier because of its high hydrophilicity (13) . Acutely administered radio labelled atenolol was reportedly undetectable by auto radiography in rat brain (14) , and a recent study using positron emission tomography has revealed that the pas sage of atenolol into the brain is very limited (15) . Taken together, the present finding suggests the involvement of /3-adrenergic systems, especially peripheral X31-adrenergic systems, in the paeoniflorin effect. However, since pro pranolol blocks not only peripheral ~1-adrenoceptors but also peripheral /2 or central (3-adrenoceptors, we cannot exclude the possible involvement of these receptor sys tems in the paeoniflorin effect.
Decker et al. (9) have reported that propranolol aug ments scopolamine-induced impairments in water maze learning and passive avoidance performance.
In the present study, both 3 mg/kg propranolol and 1 mg/kg atenolol did not potentiate the disruptive effect of scopola mine with respect to all three measures of radial maze per formance. However, both antagonists at higher doses ex hibited the tendency to aggravate the scopolamine deficit in radial maze performance, and the highest dose (6 mg/kg) of atenolol significantly increased the number of errors compared to scopolamine alone (unpublished data, H. Ohta et al.). None of these treatments by themselves impaired the maze performance in normal rats. These facts suggest that tonic activity of the ~-adrenergic sys tems may modulate the effects of scopolamine. The septohippocampal cholinergic system has been demonstrated to play an important role in radial maze per formance (16) . The fact that norepinephrine release in the septal region increases ACh turnover in the hippocampus (17) suggests the possibility that central adrenoceptor stimulation may enhance the cholinergic function in this system. However, the mechanisms for how the peripheral ~-adrenergic system modulates central cholinergic func tion remain unclear. One possible mediator might be adrenocorticotropine (ACTH). The peripheral 13-adrener gic system is suggested to modulate the plasma concentra tion of ACTH (18) , which has been reported to affect memory performance (19) . On the other hand, recent evidence suggest that glucose acts as a common mediator of some cognitive enhancers (see 20, for review). Glucose attenuates scopolamine-induced amnesia in the inhibitory avoidance task (8) and an operant bar pressing task (21) . In addition, glucose diminishes both the increase in high affinity choline uptake (21) and the decrease in striatal ACh content (22) by cholinergic antagonists. Since sym pathoadrenal activity regulates glucose release from hepat ic stores, it is likely that changes in peripheral adrenergic activity modulates central cholinergic function through the mediation of glucose. In summary, oral administration of paeoniflorin at tenuated the scopolamine-induced deficit in radial maze performance in rats. The attenuating effect of paeoniflo rin was completely blocked by either a centrally and peripherally acting j3-adrenoceptor antagonist, proprano lol, or a peripherally acting p1-selective adrenoceptor an tagonist, atenolol. These results suggest that ~-adrenergic systems, especially peripheral (31-adrenergic systems, are involved in the paeoniflorin effect.
